Literature DB >> 208426

Antibiotic-induced paralysis of the mouse phrenic nerve-hemidiaphragm preparation, and reversibility by calcium and by neostigmine.

Y N Singh, A L Harvey, I G Marshall.   

Abstract

Certain antibiotics can induce neuromuscular paralysis, but the mechanism of this action is largely unknown. The purpose of this study was to compare the neuromuscular blocking potencies and reversibilities of 16 antibiotics in the isolated mouse phrenic nerve-hemidiaphragm preparation. The antibiotics tested were five aminoglycosides (neomycin, gentamicin, streptomycin, dihydrostreptomycin and kanamycin), tetracycline and oxytetracycline, polymyxins B and E, penicillins G and V, cephradine, cephaloridine, erythromycin, lincomycin, and clindamycin. Reversibility of the muscle paralysis by calcium and neostigmine was assessed. All the aminoglycosides resembled magnesium in blocking neuromuscular transmission, the neuromuscular blockade being almost completely reversed (to 64-77 per cent of control) by calcium but only poorly reversed by neostigmine (to 20-67 per cent of control). Neuromuscular blockade produced by the tetracyclines was also reversed by calcium (44-104 per cent) but not by neostigmine (0-15 per cent). Neuromuscular blockade produced by the polymyxins or by lincomycin was only partially reversed by calcium (0-34 per cent). Penicillin V, erythromycin, clindamycin, polymyxin B and the tetracyclines could also produce muscle paralysis by decreasing muscle contractility. This effect on contractility was irreversible by pharmacologic means. Penicillin G, cephradine and cephaloridine possessed negligible paralyzing effects on the nerve-muscle preparation. It is concluded that the different groups of antibiotics tested act by different mechanisms and that only the calcium-induced reversal of aminoglycoside block is predictable.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 208426     DOI: 10.1097/00000542-197806000-00008

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  18 in total

Review 1.  Drug interactions with neuromuscular blockers.

Authors:  S Feldman; L Karalliedde
Journal:  Drug Saf       Date:  1996-10       Impact factor: 5.606

2.  Remifentanil does not inhibit sugammadex reversal after rocuronium-induced neuromuscular block in the isolated hemidiaphragm of the rat: an ex vivo study.

Authors:  Jae Moon Choi; Ha-Jung Kim; Hey Ran Choi; Yong Beom Kim; Hyeun Joon Bae; Hong Seuk Yang
Journal:  J Anesth       Date:  2019-09-18       Impact factor: 2.078

3.  Failure of neuromuscular blockade reversal after rocuronium in a patient who received oral neomycin.

Authors:  D L Hasfurther; P L Bailey
Journal:  Can J Anaesth       Date:  1996-06       Impact factor: 5.063

4.  The action of polymyxin B at the frog neuromuscular junction.

Authors:  N N Durant; J J Lambert
Journal:  Br J Pharmacol       Date:  1981-01       Impact factor: 8.739

5.  Side-effects due to the intravenous infusion of erythromycin lactobionate.

Authors:  R Putzi; J Blaser; R Lüthy; R Wehrli; W Siegenthaler
Journal:  Infection       Date:  1983 May-Jun       Impact factor: 3.553

6.  Determination of therapeutic equivalence of generic products of gentamicin in the neutropenic mouse thigh infection model.

Authors:  Andres F Zuluaga; Maria Agudelo; John J Cardeño; Carlos A Rodriguez; Omar Vesga
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

7.  Clindamycin-induced neuromuscular blockade.

Authors:  O al Ahdal; D R Bevan
Journal:  Can J Anaesth       Date:  1995-07       Impact factor: 5.063

8.  An inhibitory action of tetracyclines on guinea-pig myenteric plexus.

Authors:  A Anadón; M R Martinez-Larrañaga
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-02       Impact factor: 3.000

Review 9.  Neurological manifestations and toxicities of the antituberculosis drugs. A review.

Authors:  M R Holdiness
Journal:  Med Toxicol       Date:  1987 Jan-Feb

10.  Effect of neomycin on post-tetanic twitch tension of the mouse diaphragm preparation.

Authors:  M C Tsai
Journal:  Br J Pharmacol       Date:  1987-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.